B. Riley Securities Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $81
Benzinga Newsdesk 7 hours ago
Analyst RatingsNewsPrice Target
B. Riley Securities analyst Madison El-Saadi maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $70 to $81.
B. Riley Securities analyst Madison El-Saadi maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $70 to $81.